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Retinopathy of prematurity (ROP) is a multifactorial vasoproliferative disorder affecting prematurely born, immature infants, and infants with low (LBW) and very low birth weight (VLBW). It is among the leading causes of preventable irreversible blindness in children worldwide. [1] [2] [3] The disease is practically unknown in low income countries because of undeveloped neonatology. In high income countries in Western Europe, North America and Japan with highly developed neonatology care, very low birthweight (VLBW) and extremely low birth weight (ELBW) infants survive. These countries have well functioning screening and treatment programs and the disease is under control. In middle income countries, to which Bulgaria belongs, obstetrics and gynecology, and neonatology show an undoubted progress. This makes ROP a signifi cant problem.
Timely, continuous screening of patients at risk is the only way to preserve the vision in these babies. Finding signifi cant and independent risk factors for the development and progression of ROP to treatment-requiring stages is extremely important for ophthalmologists and neonatologists that work with the little patients. The research on the various risk factors is extensive in literature. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Finding an easily applicable and noninvasive prognostic model for the expected course of ROP is a keystone in controlling this socially signifi cant disease. This will allow us to focus the limited human and fi nancial resource in Bulgaria on patients at risk.
In Bulgaria, there is a national strategy for screening and treatment of ROP which was developed in 2009. 20 The Apgar score at 5 minutes (Apgar 5) is an indicator routinely used by Bulgarian neonatologists to get information about how well the newborn is adapting to the environment. A low Apgar 5 has been demonstrated to be a risk factor for the development and progression of ROP either alone 8, 10, 12 , or in combination with other perinatal indexes 13, 14 .
AIM
The aim of the current study was to examine the prognostic value of Apgar 5 for the development of any signs of ROP and for progression of a manifested disease to stages requiring treatment.
MATERIALS AND METHODS
Over 3 years, 132 prematurely born infants were screened in accordance with the adopted national strategy in Bulgaria for screening and treatment of ROP. 20 Examinations were performed by binocular indirect ophthalmoscopy (Fig. 1 ) after mydriasis and topical anesthesia. Eyelid retractors and scleral depressors were used to reach the far retinal periphery (Fig. 2) . The screening started 4 weeks after birth and was performed every 1 or 2 weeks according to the ocular fi ndings until complete vascularization of the retina. Treatment was administered in all cases with type 1 ROP. 20, 21 In a specially designed questionnaire for each baby we gathered information about 15 presumable maternal risk factors (number of pregnancy, desired/undesired pregnancy, previous abortions, previous preterm births, type of conception, infections during pregnancy, bleeding during pregnancy, cervical manipulations, drug intake during pregnancy, preeclampsia/eclampsia, status of placenta, umbilical cord, amniotic sac, amniotic fl uid, type of birth) and 20 presumable infant risk factors (birth weight, gestational age, gender, degree of prematurity, singletons/multiplets, Apgar score at 1 and 5 minutes; weight gain at 6 weeks (absolute and relative), days of intapulmonary ventilation, days of following oxygen therapy, total days of oxygen supplementation, surfactant application, respiratory distress syndrome, neonatal sepsis, number of blood and plasma transfusions, intraventricular hemorrhage, posthemorrhagic hydrocephaly, periventricular leukomalacia, clinically signifi cant hyperbilirubinemia) for development and progression of ROP.
All 132 screened patients were divided into: Group I -infants with no signs of ROP -92 Group II -infants with some signs of ROP -40 Group II was subdivided into: Group IIA -spontaneously regressed infants -24 Group IIB -infants progressing to stages requiring treatment - 16 Apgar 5 was calculated by a neonatologist on the basis of the indexes given in Table 1 .
Apgar 5 score ≤ 3 indicated severe postnatal depression, Apgar 5 score between 4 and 6 showed moderate postnatal depression, and Apgar 5 score between 7 and 10 was considered optimal.
Statistical analysis was performed using MS Excel and R-statistics (www.r-project.org). MannWhitney U test, χ 2 or Fisher's exact test were used for comparison between groups. A p value less than 0.05 was considered statistically signifi cant. Logistic regression was performed for fi nding independent signifi cant risk factors for either development, or progression of ROP to stages requiring treatment.
RESULTS
We had Apgar 5 score for 118 out of 132 screened premature babies. Two of them were born at home, and 12 were on intrapulmonary ventilation because of very low Apgar score at 1 minute (Fig. 3) .
Statistical analysis showed no signifi cant difference between infants with no signs of ROP and those with some signs of ROP (group I vs group II) (Fisher's exact test, p=0.191). However, there was statistically signifi cant difference between spontaneously regressed infants and those progressed to stages requiring treatment (group IIA vs group IIB) (Fisher's exact test, p=0.046). Despite the borderline yet signifi cant difference between spontaneously regressed and treated children, almost half of the treated preterm babies (group IIB) had Apgar 5 score ≤ 6 (moderate or severe postnatal depression). In group IIA (spontaneously regressed) we had no child with Apgar 5 score ≤ 3 (severe postnatal depression). We therefore combined the prematurely born infants with severe depression (Apgar 5 score ≤3) and those with moderate depression (Apgar 5 score between 4 and 6) in a common group with Apgar 5 score ≤ 6 and compared them with the infants with optimal Apgar 5 score (≤ 7). (Fig. 4) .
Statistical analysis again showed no statistical difference between infants with no signs of ROP and those with some signs of ROP (group I vs group II) (Fisher's exact test, p=0.191), but the signifi cant difference between the spontaneously regressed and the treated infants slightly increased (group IIA vs group IIB) (Fisher's exact test, p=0.036).
As shown by the logistic regression analysis, Apgar 5 ≤ 6 turned out to be not only a signifi cant risk factor, but also an independent risk factor for progression of ROP to stages requiring treatment (OR 0.174; 95% CI 0.040-0.759). Folia Medica I 2017 I Vol. 59 I No. 1
DISCUSSION
Birth weight and gestational age are currently considered the most important risk factors for development of ROP; they determine the screening criteria all over the world. [2] [3] [4] [5] 11, 20 Survival of more immature and prematurely born children leads to increasing number of patients who need regular ophthalmological screening. Early determination of high risk patients that develop ROP requiring treatment will results in having an adequate therapeutic approach to them. Thus unnecessary examinations of low risk patients can be avoided. The Apgar score in 5 minutes was examined in this study as it is routinely used in Bulgarian neonatology units, it is noninvasive and easily applicable.
In a study of 957 patients, Ke et al. 8 also found the low Apgar score at 5 minutes to be a signifi cant risk factor for the development and progression of ROP to stages requiring treatment. The subsequent logistic regression though did not fi nd it to be an independent factor. Fortes Filho et al. 13 showed that SNAPPE -II score was a signifi cant risk factor for development of any signs of ROP, as well as for severe ROP in 304 prematurely born children. One of the parameters of this score was Apgar 5 score ≤ 7 (i.e. any or no depression 5 minutes after birth, nevertheless severe (Apgar 5 ≤ 3), or moderate (Apgar 5 between 4 and 6)). Authors compared infants with no signs of ROP with children with any stage ROP, and babies with no signs of ROP with babies with severe ROP (requiring treatment). No comparison between spontaneously regressed and progressed to treatment patients was performed.
Garcia-Serrano et al. 12 examined different risk factors for development of "plus" disease among prematurely born multiplets and found low Apgar 5 score to be a signifi cant and independent risk factor after logistic regression. They did not examine prematurely born singletons. There have been speculations in literature about different reasons leading to premature birth in singletons and multiplets, suggesting preterm born multiplets being generally healthier than preterm born singletons. 22 Again authors compared children with no signs of ROP with treated children ("plus" disease is an indication for treatment worldwide).
In retrospective analysis of 252 very low birth weight (VLBW) children (birth weight < 1500 g), Yang et al. 10 also found low Apgar 5 score to be a signifi cant factor for development of ROP requiring treatment. Again comparison between children with no signs of ROP and treated children was performed.
Despite the presence of international classifi cation of ROP 21,23 , we found considerable terminological diversity in current literature. This made it diffi cult for us to interpret and compare the results of other researchers. Some used terms such as mild and severe ROP, others -treatment requiring ROP and ROP requiring no treatment, or threshold ROP. There were different criteria among the compared groups as well. Infants with no signs of ROP were compared with treated infants (equal to comparison between our group I with group IIB). 5, 10, 12, 13, 15 Patients with no signs of ROP were compared with patients with any signs of ROP (equal to comparison between our group I with group II). 5, 13, 15 Relatively small number of authors compared spontaneously regressed babies with patients progressed to stages requiring treatment (as we did in the current study). 8, 11, 15 Possible explanation of that fact could be the natural course of the disease. Not every prematurely born child will show any signs of ROP. Most of the children with manifested disease show spontaneous regression. This leads to diffi culties in gathering suffi ciently large groups of patients and makes us recommend careful interpretation of the results.
CONCLUSION
The undoubted advances in neonatology lead to survival of more and more immature and prematurely born children. Finding signifi cant and independent noninvasive prognostic factors to timely discriminate patients who will progress to stages requiring treatment from spontaneously regressing patients is pivotal in controlling ROP. This will reduce the unnecessary ophthalmological examinations without missing patients at risk. The Apgar score at 5 minutes of 6 or less is noninvasive, routinely used index in neonatology, and in the current study proved to be signifi cant and independent risk factor for progression of manifested ROP to stages requiring treatment. 
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